Remsons Industries Limited (REMSONSIND)
Outcome of Board Meeting
FY2026 results (audited):
Standalone:
Revenue 331.4bn +22% y-y (271.3bn)
EBITDA 31.0bn +x% y-y (21.7bn) # EBITDA derived from PBT + D&A + Finance Costs - Other Income
EBITDA margin 9.4% (8.0%) +140 bps y-y
PAT 11.8bn +x% y-y (9.5bn)
Consolidated:
Revenue 360.6bn +19% y-y (302.0bn)
EBITDA 34.6bn +x% y-y (24.6bn) # EBITDA derived similarly
EBITDA margin 9.6% (8.1%) +150 bps y-y
PAT 16.9bn +x% y-y (14.2bn)
Dividend: Not stated
Commentary: The company operates in a single segment, automotive components. The results were approved by the Board on 7th November 2026 and reviewed by auditors with no material misstatements noted.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 REMSONSIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add REMSONSIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Remsons Industries Limited
Important.
The summary above is generated automatically from Remsons Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.